Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

Greater awareness of an effective drug-free treatment for the massive seasonal increase in people presenting with depression could offer major benefits to overworked GPs and the NHS at large.

Incidence of depression has risen to an estimated 1 in 4 people and the latest Healthcare Commission review says that the NHS is failing to meet the demand because of over-stretched resources. With a lack of specialist therapists and counsellors many doctors are resorting to anti-depressant medication such as Prozac.

With winter drawing in the incidences of depression will rise still further. It is expected that up to 5% of people will suffer Seasonal Affective Disorder with diagnosed clinical depression. But up to 40% could present with less serious, but still debilitating, seasonal depression often categorised as winter blues.

For these people there is now an effective drug-free treatment. Results of a three year double-blind, controlled clinical trial show that Light Therapy is just as effective as the antidepressant, Fluoxetine (Prozac) in the treatment of Winter Seasonal Affective Disorder (SAD). The key advantage is that light therapy has a more rapid onset and fewer adverse side effects. Light therapy can be effective within a day or two.

The research published in the American Journal of Psychiatry was headed Raymond W Lam, a member of the medical advisory panel to The Litebook.

In a separate 3 year 6 centre clinical trial researchers concluded that “Treatment with The Litebook is an effective treatment for SAD as assessed by both clinicians (SIGH-SAD, CGI) and patients (BDI). The short treatment time (30 minutes) and portability of the device may increase patient appeal and adherence over other treatment options, including chemical anti-depressants and other light therapy devices.”

The Litebook is a revolutionary personal LED light therapy device. The patented bright white LEDs produce light at just the right wavelengths to achieve the maximum effective suppression of the sleep hormone melatonin in the shortest possible time. Many users can manage their symptoms with just 15 minutes exposure each morning. It is the ineffective suppression of melatonin on dark mornings and in low light environments that is the cause of seasonal depression.

For more information and full details of clinical trials visit


For more information and interviews contact Barry Fowler 0117 968 0161 or

light therapy,SAD,seasonal affective disorder,winter blues,seasonal depression,prozac,litebook

This press release was distributed by ResponseSource Press Release Wire on behalf of SPM Ltd in the following categories: Men's Interest, Health, Women's Interest & Beauty, Education & Human Resources, Medical & Pharmaceutical, Public Sector, Third Sector & Legal, for more information visit